Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1613729 | 1.00 | GBA1 (0.31) | GBA1 | |
| SCHEMBL1613710 | 0.78 | GBA1 (0.36) | GBA1 | |
| SCHEMBL283742 | 0.72 | — | — | |
| SCHEMBL3787675 | 0.70 | — | — | |
| SCHEMBL4955259 | 0.64 | LMNA (0.33) | — | |
| SCHEMBL1864491 | 0.64 | — | — | |
| SCHEMBL14567103 | 0.64 | LMNA (0.33) | — | |
| SCHEMBL22037294 | 0.63 | ALDH1A1 (0.44) | GBA1 | |
| SCHEMBL8328254 | 0.60 | — | — | |
| SCHEMBL3912834 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 290 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025090061-A1 | ULTRASONIC INDICATOR DEVICE AND METHOD FOR MONITORING ULTRASONICATION | JP LABORATORIES, INC. (US) | 2025-05-01 | — | — | WO | claimed |
| WO-2025075611-A1 | ULTRASONIC INDICATOR BASED ON EMULSION FORMATION | JP LABORATORIES, INC. (US) | 2025-04-10 | — | — | WO | claimed |
| US-20230149562-A1 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | TIBA BIOTECH LLC (US) | 2023-05-18 | — | — | US | claimed |
| EP-4132586-A1 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | Tiba Biotech LLC (US) | 2023-02-15 | — | — | EP | claimed |
| EP-3285942-A1 | PROCESS FOR THE PREPARATION OF METALLIC NANO-PARTICLE LAYERS AND THEIR USE FOR DECORATIVE OR SECURITY ELEMENTS | BASF SE (DE) | 2018-02-28 | — | — | EP | claimed |
| WO-2016170160-A1 | PROCESS FOR THE PREPARATION OF METALLIC NANO-PARTICLE LAYERS AND THEIR USE FOR DECORATIVE OR SECURITY ELEMENTS | BASF SE (DE) | 2016-10-27 | — | — | WO | claimed |
| EP-1186596-B1 | PROCESS FOR THE PRODUCTION OF 2-PYRIDYLPYRIDINE DERIVATIVES | SANKIO CHEMICAL CO LTD (JP) | 2004-03-17 | — | — | EP | claimed |
| US-20260014077-A1 | NOVEL METHODS TO ENHANCE GENE DELIVERY | TIBA BIOTECH LLC (US) | 2026-01-15 | — | — | US | disclosed |
| US-20250326754-A1 | DNA-PK Inhibitor Compounds and Uses Thereof | ADMARE THERAPEUTICS SOC (CA) | 2025-10-23 | — | — | US | disclosed |
| US-12377100-B2 | Toll like receptor modulator compounds | GILEAD SCIENCES, INC. (US) | 2025-08-05 | — | — | US | disclosed |
| WO-2025090061-A1 | ULTRASONIC INDICATOR DEVICE AND METHOD FOR MONITORING ULTRASONICATION | JP LABORATORIES, INC. (US) | 2025-05-01 | — | — | WO | disclosed |
| WO-2025075611-A1 | ULTRASONIC INDICATOR BASED ON EMULSION FORMATION | JP LABORATORIES, INC. (US) | 2025-04-10 | — | — | WO | disclosed |
| EP-4522620-A1 | DNA-PK INHIBITOR COMPOUNDS AND USES THEREOF | Admare Therapeutics Society (CA) | 2025-03-19 | — | — | EP | disclosed |
| US-4643255-A | CROSSLINKING POLYVINYL ALCOHOL WITH AN ALDEHYDE | CITIES SERVICE OIL AND GAS CORPORATION (US) | 1987-02-17 | — | — | US | disclosed |
| EP-0188856-A1 | Gel and process for retarding fluid flow | CITIES SERVICE OIL & GAS CORPORATION (US) | 1986-07-30 | — | — | EP | disclosed |
| EP-0186663-A1 | GEL AND PROCESS FOR RETARDING FLUID FLOW. | CITIES SERVICE OIL & GAS (US) | 1986-07-09 | — | — | EP | disclosed |
| WO-1986000330-A1 | GEL AND PROCESS FOR RETARDING FLUID FLOW | CITIES SERVICE OIL AND GAS CORPORATION (US) | 1986-01-16 | — | — | WO | disclosed |
| US-4498540-A | POLYVINYL ALCOHOL-ALDEHYDE GEL | CITIES SERVICE OIL AND GAS CORPORATION (US) | 1985-02-12 | — | — | US | disclosed |
| EP-0078365-A1 | Composition and process for modifying gelation of alkali metal silicates | DIAMOND SHAMROCK CORPORATION (US) | 1983-05-11 | — | — | EP | disclosed |
| US-4354875-A | STABILIZING SOILS | DIAMOND SHAMROCK CORPORATION (US) | 1982-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230149562-A1 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | POLN, TLR9, TSG101 | GBA1 1015/4885 |
| US-12377100-B2 | Toll like receptor modulator compounds | TLR8, TLR3, TLR6 | GBA1 4077/4885 |
| US-20250326754-A1 | DNA-PK Inhibitor Compounds and Uses Thereof | DCK, CHEK1, CHEK2 | GBA1 2668/4885 |
| US-20260014077-A1 | NOVEL METHODS TO ENHANCE GENE DELIVERY | LDLR, NPC1L1, LIPG | GBA1 1802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.